| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 77 | 2024 | 976 | 12.430 |
Why?
|
| Genome-Wide Association Study | 48 | 2023 | 1670 | 5.070 |
Why?
|
| Genetic Predisposition to Disease | 55 | 2022 | 2335 | 4.140 |
Why?
|
| HLA Antigens | 24 | 2019 | 227 | 3.960 |
Why?
|
| Founder Effect | 21 | 2018 | 104 | 3.180 |
Why?
|
| DNA Methylation | 15 | 2024 | 657 | 3.060 |
Why?
|
| Polymorphism, Single Nucleotide | 57 | 2023 | 2399 | 2.830 |
Why?
|
| Histocompatibility Antigens Class I | 15 | 2016 | 200 | 2.640 |
Why?
|
| Alleles | 39 | 2022 | 1135 | 2.460 |
Why?
|
| Genetic Association Studies | 6 | 2023 | 294 | 2.330 |
Why?
|
| Pedigree | 30 | 2019 | 969 | 2.010 |
Why?
|
| Genotype | 35 | 2023 | 1848 | 1.930 |
Why?
|
| Hypersensitivity | 8 | 2024 | 158 | 1.900 |
Why?
|
| Gene Frequency | 24 | 2021 | 685 | 1.760 |
Why?
|
| Quantitative Trait Loci | 22 | 2021 | 607 | 1.660 |
Why?
|
| Polymorphism, Genetic | 14 | 2018 | 824 | 1.560 |
Why?
|
| Epigenesis, Genetic | 12 | 2023 | 506 | 1.560 |
Why?
|
| HLA-G Antigens | 15 | 2013 | 52 | 1.520 |
Why?
|
| Haplotypes | 23 | 2021 | 637 | 1.500 |
Why?
|
| Humans | 175 | 2024 | 89063 | 1.490 |
Why?
|
| Hypersensitivity, Immediate | 8 | 2020 | 63 | 1.490 |
Why?
|
| Lung | 7 | 2023 | 1258 | 1.470 |
Why?
|
| Child | 40 | 2023 | 7149 | 1.460 |
Why?
|
| Linkage Disequilibrium | 15 | 2020 | 477 | 1.440 |
Why?
|
| Genetic Variation | 21 | 2021 | 1371 | 1.430 |
Why?
|
| Quantitative Trait, Heritable | 8 | 2017 | 124 | 1.260 |
Why?
|
| Gene Expression Regulation | 15 | 2024 | 1975 | 1.220 |
Why?
|
| Chromosomes, Human, Pair 17 | 6 | 2021 | 111 | 1.220 |
Why?
|
| Female | 102 | 2024 | 46011 | 1.180 |
Why?
|
| Phenotype | 21 | 2023 | 2439 | 1.160 |
Why?
|
| Chromosome Mapping | 19 | 2017 | 1076 | 1.160 |
Why?
|
| Adult | 63 | 2024 | 26507 | 1.160 |
Why?
|
| Pregnancy | 27 | 2023 | 3009 | 1.150 |
Why?
|
| Sex Characteristics | 8 | 2021 | 324 | 1.140 |
Why?
|
| Premature Birth | 3 | 2023 | 117 | 1.110 |
Why?
|
| Environment | 4 | 2016 | 224 | 1.060 |
Why?
|
| MicroRNAs | 3 | 2021 | 551 | 1.060 |
Why?
|
| Genome, Human | 14 | 2015 | 767 | 1.040 |
Why?
|
| Male | 86 | 2024 | 42251 | 1.000 |
Why?
|
| Integrin beta3 | 6 | 2007 | 32 | 0.990 |
Why?
|
| Epithelial Cells | 7 | 2023 | 688 | 0.940 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2023 | 275 | 0.930 |
Why?
|
| Adolescent | 26 | 2023 | 9237 | 0.910 |
Why?
|
| Abortion, Habitual | 6 | 2015 | 33 | 0.900 |
Why?
|
| Labor, Obstetric | 1 | 2023 | 46 | 0.860 |
Why?
|
| Interleukin-13 | 4 | 2022 | 38 | 0.860 |
Why?
|
| Gene Expression Profiling | 9 | 2021 | 1429 | 0.860 |
Why?
|
| Obstetric Labor, Premature | 1 | 2023 | 58 | 0.850 |
Why?
|
| Models, Genetic | 14 | 2019 | 944 | 0.850 |
Why?
|
| Transcription, Genetic | 4 | 2021 | 1157 | 0.850 |
Why?
|
| Leukocytes | 4 | 2021 | 204 | 0.820 |
Why?
|
| Pre-Eclampsia | 3 | 2012 | 254 | 0.810 |
Why?
|
| South Dakota | 16 | 2015 | 47 | 0.810 |
Why?
|
| Nuclear Family | 4 | 2019 | 92 | 0.770 |
Why?
|
| Fertility | 7 | 2019 | 116 | 0.770 |
Why?
|
| Genetic Linkage | 12 | 2011 | 624 | 0.770 |
Why?
|
| Sequence Deletion | 4 | 2014 | 205 | 0.760 |
Why?
|
| Consanguinity | 6 | 2019 | 73 | 0.750 |
Why?
|
| Chromosomes, Human, Pair 6 | 4 | 2012 | 125 | 0.740 |
Why?
|
| Promoter Regions, Genetic | 8 | 2021 | 956 | 0.740 |
Why?
|
| Nose | 2 | 2020 | 94 | 0.720 |
Why?
|
| Cardiovascular Diseases | 5 | 2016 | 705 | 0.710 |
Why?
|
| Immunity, Mucosal | 3 | 2021 | 69 | 0.710 |
Why?
|
| Microbiota | 4 | 2020 | 398 | 0.700 |
Why?
|
| Case-Control Studies | 17 | 2024 | 1855 | 0.700 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2019 | 10 | 0.700 |
Why?
|
| Gene Regulatory Networks | 4 | 2024 | 308 | 0.690 |
Why?
|
| Immunoglobulin E | 9 | 2021 | 145 | 0.680 |
Why?
|
| Respiratory Hypersensitivity | 4 | 2007 | 41 | 0.680 |
Why?
|
| Immunity, Innate | 4 | 2021 | 429 | 0.670 |
Why?
|
| Genetics, Population | 7 | 2012 | 405 | 0.660 |
Why?
|
| Farms | 2 | 2023 | 7 | 0.660 |
Why?
|
| Serotonin | 6 | 2006 | 221 | 0.650 |
Why?
|
| Abortion, Spontaneous | 5 | 2006 | 66 | 0.640 |
Why?
|
| Genomic Imprinting | 1 | 2018 | 33 | 0.640 |
Why?
|
| Gene-Environment Interaction | 3 | 2016 | 111 | 0.640 |
Why?
|
| Cytokines | 10 | 2022 | 802 | 0.630 |
Why?
|
| Immunologic Memory | 1 | 2019 | 162 | 0.630 |
Why?
|
| Rhinitis | 3 | 2023 | 178 | 0.620 |
Why?
|
| Receptors, IgG | 1 | 2018 | 53 | 0.620 |
Why?
|
| CD3 Complex | 1 | 2018 | 134 | 0.620 |
Why?
|
| CD28 Antigens | 1 | 2018 | 90 | 0.620 |
Why?
|
| Puberty | 1 | 2018 | 60 | 0.610 |
Why?
|
| Sinusitis | 3 | 2023 | 214 | 0.610 |
Why?
|
| Reproduction | 4 | 2015 | 199 | 0.610 |
Why?
|
| Population | 1 | 2017 | 35 | 0.590 |
Why?
|
| RNA, Untranslated | 1 | 2017 | 65 | 0.590 |
Why?
|
| Mutation | 10 | 2012 | 4132 | 0.580 |
Why?
|
| Th2 Cells | 3 | 2019 | 147 | 0.580 |
Why?
|
| Estrogens | 1 | 2018 | 201 | 0.580 |
Why?
|
| Actinobacteria | 1 | 2017 | 11 | 0.580 |
Why?
|
| Enhancer Elements, Genetic | 5 | 2021 | 280 | 0.570 |
Why?
|
| Leukocytes, Mononuclear | 6 | 2022 | 207 | 0.570 |
Why?
|
| Middle Aged | 30 | 2024 | 25863 | 0.570 |
Why?
|
| Nasopharynx | 1 | 2017 | 50 | 0.570 |
Why?
|
| Respiratory Sounds | 4 | 2021 | 34 | 0.560 |
Why?
|
| Young Adult | 15 | 2021 | 6288 | 0.560 |
Why?
|
| Genes, Recessive | 3 | 2015 | 87 | 0.560 |
Why?
|
| Genes, MHC Class I | 4 | 2021 | 48 | 0.560 |
Why?
|
| Neoplasm Proteins | 6 | 2022 | 540 | 0.550 |
Why?
|
| Genetic Testing | 5 | 2012 | 537 | 0.550 |
Why?
|
| Antibodies | 1 | 2018 | 353 | 0.540 |
Why?
|
| Immunophenotyping | 4 | 2019 | 217 | 0.540 |
Why?
|
| Lipids | 1 | 2017 | 271 | 0.530 |
Why?
|
| Parents | 1 | 2019 | 285 | 0.530 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2006 | 109 | 0.520 |
Why?
|
| Agriculture | 2 | 2016 | 39 | 0.520 |
Why?
|
| Lymph Nodes | 1 | 2019 | 548 | 0.520 |
Why?
|
| Allergens | 7 | 2023 | 183 | 0.520 |
Why?
|
| Rural Population | 2 | 2017 | 143 | 0.510 |
Why?
|
| DNA, Mitochondrial | 3 | 2012 | 187 | 0.500 |
Why?
|
| Transcriptome | 6 | 2021 | 628 | 0.490 |
Why?
|
| Chromosome Disorders | 2 | 2012 | 115 | 0.490 |
Why?
|
| Infant, Newborn | 12 | 2023 | 2476 | 0.490 |
Why?
|
| Pore Forming Cytotoxic Proteins | 3 | 2022 | 54 | 0.470 |
Why?
|
| Interferon-gamma | 2 | 2018 | 451 | 0.470 |
Why?
|
| Genetic Carrier Screening | 2 | 2011 | 60 | 0.460 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2010 | 56 | 0.460 |
Why?
|
| Genetic Loci | 8 | 2022 | 253 | 0.460 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2013 | 8 | 0.450 |
Why?
|
| beta-Defensins | 1 | 2013 | 12 | 0.450 |
Why?
|
| Aged | 19 | 2022 | 19077 | 0.450 |
Why?
|
| Respiratory Mucosa | 3 | 2020 | 88 | 0.450 |
Why?
|
| Microsatellite Repeats | 6 | 2008 | 147 | 0.450 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 38 | 0.450 |
Why?
|
| Risk Factors | 15 | 2023 | 5466 | 0.450 |
Why?
|
| Chemokines, CC | 1 | 2013 | 36 | 0.450 |
Why?
|
| Heterozygote | 6 | 2018 | 373 | 0.440 |
Why?
|
| Gene Expression | 7 | 2021 | 1310 | 0.430 |
Why?
|
| Chimerism | 1 | 2013 | 37 | 0.430 |
Why?
|
| HLA-DQ beta-Chains | 5 | 2021 | 12 | 0.430 |
Why?
|
| Bronchial Hyperreactivity | 4 | 2020 | 77 | 0.430 |
Why?
|
| Genome, Mitochondrial | 1 | 2012 | 27 | 0.420 |
Why?
|
| Infant | 11 | 2022 | 3147 | 0.410 |
Why?
|
| Trophoblasts | 4 | 2021 | 33 | 0.400 |
Why?
|
| Rhinovirus | 4 | 2023 | 25 | 0.400 |
Why?
|
| Obesity | 4 | 2021 | 966 | 0.390 |
Why?
|
| Respiration | 1 | 2013 | 267 | 0.390 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2011 | 4 | 0.390 |
Why?
|
| Sex Factors | 8 | 2014 | 1063 | 0.390 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2011 | 24 | 0.390 |
Why?
|
| Interleukin-4 | 3 | 2022 | 130 | 0.390 |
Why?
|
| Bayes Theorem | 3 | 2022 | 369 | 0.380 |
Why?
|
| Gene Deletion | 1 | 2012 | 342 | 0.380 |
Why?
|
| Rhinitis, Allergic | 2 | 2022 | 45 | 0.380 |
Why?
|
| Lipoprotein(a) | 2 | 2009 | 29 | 0.380 |
Why?
|
| Population Groups | 3 | 2014 | 41 | 0.370 |
Why?
|
| Sequence Analysis, DNA | 7 | 2015 | 866 | 0.360 |
Why?
|
| Homozygote | 7 | 2019 | 204 | 0.350 |
Why?
|
| Olfactory Perception | 1 | 2010 | 21 | 0.350 |
Why?
|
| Biomarkers | 5 | 2020 | 1755 | 0.340 |
Why?
|
| Child, Preschool | 10 | 2021 | 3717 | 0.340 |
Why?
|
| Receptors, Odorant | 1 | 2010 | 37 | 0.340 |
Why?
|
| Multigene Family | 1 | 2010 | 203 | 0.330 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 6777 | 0.330 |
Why?
|
| Amish | 2 | 2019 | 6 | 0.320 |
Why?
|
| United States | 11 | 2024 | 6955 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 79 | 0.320 |
Why?
|
| Antigens, Differentiation | 2 | 1999 | 141 | 0.310 |
Why?
|
| Marriage | 2 | 1999 | 25 | 0.310 |
Why?
|
| Family Characteristics | 2 | 2009 | 48 | 0.310 |
Why?
|
| DNA | 5 | 2023 | 1307 | 0.310 |
Why?
|
| Cohort Studies | 9 | 2021 | 2863 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2008 | 48 | 0.310 |
Why?
|
| Disease | 1 | 2008 | 90 | 0.310 |
Why?
|
| Protein Isoforms | 1 | 2009 | 274 | 0.300 |
Why?
|
| Immunoconjugates | 2 | 1999 | 110 | 0.300 |
Why?
|
| Evolution, Molecular | 3 | 2012 | 839 | 0.300 |
Why?
|
| Chromatin | 5 | 2021 | 397 | 0.300 |
Why?
|
| Interleukin-33 | 2 | 2021 | 25 | 0.300 |
Why?
|
| Intergenerational Relations | 1 | 2007 | 5 | 0.300 |
Why?
|
| CpG Islands | 3 | 2023 | 157 | 0.290 |
Why?
|
| Algorithms | 7 | 2019 | 1875 | 0.290 |
Why?
|
| Mothers | 3 | 2022 | 142 | 0.290 |
Why?
|
| Base Sequence | 7 | 2010 | 2327 | 0.290 |
Why?
|
| Social Isolation | 1 | 2007 | 67 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 19 | 4 | 2012 | 59 | 0.290 |
Why?
|
| Olfaction Disorders | 1 | 2008 | 68 | 0.280 |
Why?
|
| Glycoproteins | 1 | 2008 | 234 | 0.280 |
Why?
|
| Membrane Proteins | 4 | 2022 | 1215 | 0.280 |
Why?
|
| Placenta | 4 | 2021 | 179 | 0.280 |
Why?
|
| Smell | 2 | 2005 | 111 | 0.280 |
Why?
|
| T-Lymphocytes | 4 | 2020 | 1223 | 0.270 |
Why?
|
| Major Histocompatibility Complex | 2 | 2005 | 83 | 0.260 |
Why?
|
| Surveys and Questionnaires | 2 | 2011 | 2612 | 0.260 |
Why?
|
| Epigenomics | 2 | 2020 | 103 | 0.260 |
Why?
|
| Genetics, Medical | 1 | 2006 | 52 | 0.260 |
Why?
|
| Genes, X-Linked | 2 | 2021 | 38 | 0.260 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2005 | 11 | 0.260 |
Why?
|
| Child Day Care Centers | 1 | 2005 | 6 | 0.250 |
Why?
|
| Dust | 2 | 2023 | 26 | 0.250 |
Why?
|
| Triglycerides | 2 | 2003 | 232 | 0.250 |
Why?
|
| Genes, MHC Class II | 2 | 2021 | 30 | 0.250 |
Why?
|
| Aging | 2 | 2007 | 716 | 0.250 |
Why?
|
| Prevalence | 4 | 2017 | 1240 | 0.240 |
Why?
|
| Immune Tolerance | 2 | 2005 | 337 | 0.240 |
Why?
|
| Lipoproteins | 1 | 2005 | 136 | 0.240 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2024 | 9 | 0.240 |
Why?
|
| Common Cold | 2 | 2015 | 13 | 0.240 |
Why?
|
| Dermatomyositis | 1 | 2004 | 18 | 0.240 |
Why?
|
| Chimera | 1 | 2004 | 56 | 0.240 |
Why?
|
| Biometry | 1 | 2004 | 66 | 0.230 |
Why?
|
| Animals | 17 | 2023 | 27317 | 0.230 |
Why?
|
| Fetus | 3 | 2005 | 232 | 0.230 |
Why?
|
| Environmental Exposure | 4 | 2022 | 322 | 0.230 |
Why?
|
| Perception | 1 | 2005 | 178 | 0.230 |
Why?
|
| Nasal Mucosa | 1 | 2024 | 191 | 0.230 |
Why?
|
| Multifactorial Inheritance | 2 | 2023 | 169 | 0.220 |
Why?
|
| Maternal-Fetal Exchange | 3 | 1999 | 77 | 0.220 |
Why?
|
| Receptors, Muscarinic | 1 | 2003 | 48 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2003 | 85 | 0.210 |
Why?
|
| Gastrointestinal Tract | 2 | 2015 | 191 | 0.210 |
Why?
|
| HLA-DQ Antigens | 3 | 2004 | 51 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2003 | 86 | 0.210 |
Why?
|
| Respiratory System | 2 | 2023 | 116 | 0.210 |
Why?
|
| Nasal Polyps | 1 | 2023 | 60 | 0.210 |
Why?
|
| HLA-A Antigens | 4 | 1997 | 40 | 0.210 |
Why?
|
| Forced Expiratory Volume | 1 | 2023 | 124 | 0.210 |
Why?
|
| Adult Children | 1 | 2022 | 12 | 0.210 |
Why?
|
| Coenzyme A | 1 | 2022 | 15 | 0.210 |
Why?
|
| DNA Modification Methylases | 1 | 2022 | 28 | 0.210 |
Why?
|
| Patient Acuity | 1 | 2022 | 33 | 0.210 |
Why?
|
| Eosinophils | 2 | 2019 | 194 | 0.210 |
Why?
|
| Carrier Proteins | 2 | 2017 | 681 | 0.210 |
Why?
|
| Kallikreins | 3 | 2022 | 49 | 0.200 |
Why?
|
| DNA Repair Enzymes | 1 | 2022 | 55 | 0.200 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2019 | 248 | 0.200 |
Why?
|
| Dermatitis, Atopic | 2 | 2021 | 55 | 0.200 |
Why?
|
| Intellectual Disability | 3 | 2021 | 189 | 0.200 |
Why?
|
| Europe | 3 | 2017 | 321 | 0.200 |
Why?
|
| Computational Biology | 2 | 2017 | 542 | 0.200 |
Why?
|
| HLA-A2 Antigen | 1 | 2021 | 31 | 0.200 |
Why?
|
| Age of Onset | 2 | 2019 | 312 | 0.200 |
Why?
|
| B-Lymphocytes | 3 | 2014 | 738 | 0.200 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2021 | 20 | 0.200 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2021 | 7 | 0.200 |
Why?
|
| Genetic Markers | 2 | 2019 | 478 | 0.200 |
Why?
|
| Mucin 5AC | 1 | 2021 | 8 | 0.200 |
Why?
|
| Genetic Pleiotropy | 1 | 2021 | 25 | 0.190 |
Why?
|
| Odorants | 1 | 2002 | 70 | 0.190 |
Why?
|
| Amino Acids | 1 | 2022 | 245 | 0.190 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2021 | 56 | 0.190 |
Why?
|
| Fetal Viability | 3 | 1998 | 9 | 0.190 |
Why?
|
| Fucosyltransferases | 1 | 2020 | 9 | 0.190 |
Why?
|
| Air Pollutants | 1 | 2022 | 92 | 0.190 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2022 | 158 | 0.190 |
Why?
|
| B7-H1 Antigen | 1 | 2023 | 273 | 0.190 |
Why?
|
| Histocompatibility Testing | 2 | 1998 | 137 | 0.190 |
Why?
|
| Bilirubin | 1 | 2021 | 129 | 0.180 |
Why?
|
| ABO Blood-Group System | 1 | 2020 | 58 | 0.180 |
Why?
|
| Genomics | 5 | 2024 | 761 | 0.180 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 232 | 0.180 |
Why?
|
| Autoimmune Diseases | 3 | 2012 | 249 | 0.180 |
Why?
|
| Pneumococcal Infections | 1 | 2020 | 47 | 0.180 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1837 | 0.180 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 31 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2022 | 287 | 0.180 |
Why?
|
| Epistasis, Genetic | 1 | 2020 | 90 | 0.180 |
Why?
|
| Adipocytes | 1 | 2021 | 162 | 0.180 |
Why?
|
| TRPV Cation Channels | 1 | 2020 | 16 | 0.180 |
Why?
|
| HLA-DRB1 Chains | 1 | 2020 | 25 | 0.180 |
Why?
|
| Aspergillus fumigatus | 1 | 2020 | 18 | 0.180 |
Why?
|
| Inbreeding Depression | 1 | 2019 | 2 | 0.180 |
Why?
|
| Gene Ontology | 1 | 2019 | 34 | 0.170 |
Why?
|
| V(D)J Recombination | 1 | 2019 | 10 | 0.170 |
Why?
|
| Fetal Growth Retardation | 1 | 2000 | 67 | 0.170 |
Why?
|
| Inheritance Patterns | 2 | 2012 | 48 | 0.170 |
Why?
|
| Risk | 4 | 2017 | 657 | 0.170 |
Why?
|
| Urban Population | 1 | 2021 | 224 | 0.170 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2019 | 15 | 0.170 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 41 | 0.170 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 140 | 0.170 |
Why?
|
| Serine Endopeptidases | 1 | 2020 | 146 | 0.170 |
Why?
|
| Cell Line | 3 | 2021 | 2495 | 0.170 |
Why?
|
| Body Size | 1 | 2019 | 91 | 0.170 |
Why?
|
| Taboo | 1 | 1999 | 1 | 0.170 |
Why?
|
| Computer Simulation | 3 | 2005 | 1097 | 0.170 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 1999 | 19 | 0.160 |
Why?
|
| Transcription Factors | 3 | 2021 | 1652 | 0.160 |
Why?
|
| Sexual Behavior | 1 | 2002 | 309 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1999 | 51 | 0.160 |
Why?
|
| Cells, Cultured | 4 | 2020 | 2880 | 0.160 |
Why?
|
| Fungi | 1 | 2019 | 66 | 0.160 |
Why?
|
| Adipose Tissue | 1 | 2021 | 259 | 0.160 |
Why?
|
| Smoking | 1 | 2023 | 620 | 0.160 |
Why?
|
| Risk-Taking | 1 | 2019 | 155 | 0.160 |
Why?
|
| Endocrine System | 1 | 2018 | 17 | 0.160 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 382 | 0.150 |
Why?
|
| Monocytes | 1 | 1999 | 218 | 0.150 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 497 | 0.150 |
Why?
|
| Exons | 3 | 2012 | 451 | 0.150 |
Why?
|
| Neutrophils | 1 | 2019 | 308 | 0.150 |
Why?
|
| Interleukin-12 | 1 | 2018 | 109 | 0.150 |
Why?
|
| Interleukin-2 | 1 | 2018 | 251 | 0.150 |
Why?
|
| Pregnancy, Ectopic | 1 | 1998 | 36 | 0.150 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1999 | 189 | 0.150 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2016 | 481 | 0.150 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 168 | 0.150 |
Why?
|
| Health Status | 1 | 2019 | 370 | 0.150 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 556 | 0.140 |
Why?
|
| Immunity | 1 | 2018 | 141 | 0.140 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2752 | 0.140 |
Why?
|
| Chronic Disease | 3 | 2023 | 948 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 261 | 0.140 |
Why?
|
| Lymphocytes | 2 | 2018 | 471 | 0.140 |
Why?
|
| Genes, Lethal | 2 | 2015 | 53 | 0.140 |
Why?
|
| Birth Rate | 3 | 2012 | 12 | 0.140 |
Why?
|
| Christianity | 3 | 2016 | 37 | 0.140 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2016 | 38 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 921 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2018 | 695 | 0.130 |
Why?
|
| Embryonic and Fetal Development | 1 | 1995 | 72 | 0.130 |
Why?
|
| Transplantation, Homologous | 1 | 1998 | 995 | 0.130 |
Why?
|
| Embryo Loss | 1 | 2015 | 5 | 0.130 |
Why?
|
| Exome | 2 | 2012 | 127 | 0.120 |
Why?
|
| Cognition | 1 | 2019 | 580 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 304 | 0.120 |
Why?
|
| Freezing | 1 | 2014 | 32 | 0.120 |
Why?
|
| Meta-Analysis as Topic | 2 | 2012 | 86 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 699 | 0.120 |
Why?
|
| Blood Pressure | 3 | 2005 | 899 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 2 | 2014 | 119 | 0.120 |
Why?
|
| Molecular Sequence Data | 4 | 2005 | 3027 | 0.120 |
Why?
|
| Pregnancy Outcome | 3 | 2001 | 253 | 0.120 |
Why?
|
| Religion | 3 | 2012 | 88 | 0.120 |
Why?
|
| HLA-D Antigens | 1 | 1993 | 20 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 771 | 0.110 |
Why?
|
| Likelihood Functions | 3 | 2005 | 251 | 0.110 |
Why?
|
| Metagenome | 1 | 2014 | 104 | 0.110 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 139 | 0.110 |
Why?
|
| Mice | 7 | 2023 | 11737 | 0.110 |
Why?
|
| Maternal Exposure | 1 | 2013 | 58 | 0.110 |
Why?
|
| NADH Dehydrogenase | 1 | 2012 | 22 | 0.110 |
Why?
|
| Selection, Genetic | 1 | 1997 | 509 | 0.110 |
Why?
|
| Umbilical Cord | 1 | 2012 | 40 | 0.110 |
Why?
|
| Seasons | 1 | 2014 | 237 | 0.100 |
Why?
|
| Mutation Rate | 1 | 2012 | 48 | 0.100 |
Why?
|
| Untranslated Regions | 1 | 2012 | 18 | 0.100 |
Why?
|
| Autistic Disorder | 3 | 2012 | 150 | 0.100 |
Why?
|
| Body Mass Index | 3 | 2015 | 771 | 0.100 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 98 | 0.100 |
Why?
|
| Open Reading Frames | 1 | 2012 | 119 | 0.100 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2011 | 12 | 0.100 |
Why?
|
| Bacteria | 1 | 2015 | 472 | 0.100 |
Why?
|
| Montana | 1 | 2011 | 9 | 0.100 |
Why?
|
| Synaptic Membranes | 1 | 2011 | 14 | 0.100 |
Why?
|
| Cell Transformation, Viral | 1 | 2011 | 40 | 0.090 |
Why?
|
| Chicago | 2 | 2012 | 1423 | 0.090 |
Why?
|
| Interleukins | 1 | 2011 | 129 | 0.090 |
Why?
|
| Brain | 1 | 2021 | 2281 | 0.090 |
Why?
|
| Matched-Pair Analysis | 2 | 2001 | 40 | 0.090 |
Why?
|
| Software | 1 | 2015 | 665 | 0.090 |
Why?
|
| Oxidoreductases | 1 | 2011 | 112 | 0.090 |
Why?
|
| Genes, Dominant | 2 | 2001 | 117 | 0.090 |
Why?
|
| Alternative Splicing | 2 | 2005 | 210 | 0.090 |
Why?
|
| Fertilization | 1 | 2010 | 40 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 661 | 0.090 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2011 | 101 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 1 | 2012 | 359 | 0.090 |
Why?
|
| Pheromones, Human | 1 | 2010 | 7 | 0.090 |
Why?
|
| Pan troglodytes | 2 | 2005 | 199 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 3209 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 289 | 0.090 |
Why?
|
| Chromosomes, Human, Y | 1 | 2009 | 23 | 0.090 |
Why?
|
| Kringles | 1 | 2009 | 6 | 0.080 |
Why?
|
| Logistic Models | 1 | 2013 | 1212 | 0.080 |
Why?
|
| Leukocyte Count | 2 | 2016 | 223 | 0.080 |
Why?
|
| Abatacept | 2 | 1999 | 85 | 0.080 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2015 | 504 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 432 | 0.080 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2008 | 9 | 0.080 |
Why?
|
| Recombination, Genetic | 2 | 2008 | 444 | 0.080 |
Why?
|
| Adipokines | 1 | 2008 | 17 | 0.080 |
Why?
|
| CTLA-4 Antigen | 2 | 1999 | 139 | 0.080 |
Why?
|
| Lymphocyte Activation | 1 | 2011 | 751 | 0.080 |
Why?
|
| Pulmonary Ventilation | 1 | 2008 | 33 | 0.080 |
Why?
|
| Family | 2 | 2007 | 325 | 0.080 |
Why?
|
| Crossing Over, Genetic | 1 | 2008 | 33 | 0.080 |
Why?
|
| Lectins | 1 | 2008 | 84 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 2 | 2012 | 299 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2005 | 306 | 0.070 |
Why?
|
| Binding Sites | 2 | 2007 | 1117 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2008 | 354 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2008 | 216 | 0.070 |
Why?
|
| 3' Untranslated Regions | 1 | 2007 | 94 | 0.070 |
Why?
|
| Antigens, CD | 2 | 1999 | 466 | 0.070 |
Why?
|
| Insulin | 2 | 2002 | 1146 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 2014 | 0.070 |
Why?
|
| Germany | 1 | 2006 | 72 | 0.070 |
Why?
|
| Russia | 1 | 2006 | 26 | 0.070 |
Why?
|
| DNA-Cytosine Methylases | 1 | 2006 | 4 | 0.070 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2006 | 48 | 0.070 |
Why?
|
| Pseudogenes | 1 | 2005 | 34 | 0.070 |
Why?
|
| Endometrium | 2 | 2016 | 50 | 0.060 |
Why?
|
| Receptors, KIR2DL5 | 1 | 2005 | 1 | 0.060 |
Why?
|
| Histocompatibility | 1 | 1985 | 66 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 283 | 0.060 |
Why?
|
| Phagocytes | 1 | 2005 | 11 | 0.060 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2005 | 97 | 0.060 |
Why?
|
| Inflammation | 2 | 2022 | 971 | 0.060 |
Why?
|
| Interferon-beta | 1 | 2006 | 126 | 0.060 |
Why?
|
| Human Body | 1 | 2005 | 6 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2005 | 211 | 0.060 |
Why?
|
| Azacitidine | 1 | 2006 | 146 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2006 | 2011 | 0.060 |
Why?
|
| HLA-DQ alpha-Chains | 2 | 1995 | 16 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1985 | 164 | 0.060 |
Why?
|
| DNA-Binding Proteins | 3 | 2021 | 1241 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2005 | 140 | 0.060 |
Why?
|
| Maternal Age | 2 | 2008 | 45 | 0.060 |
Why?
|
| Receptors, Immunologic | 1 | 2005 | 135 | 0.060 |
Why?
|
| Antigen-Presenting Cells | 1 | 2005 | 141 | 0.060 |
Why?
|
| North America | 2 | 2011 | 184 | 0.060 |
Why?
|
| Virus Diseases | 1 | 2005 | 98 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 3657 | 0.060 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2024 | 4 | 0.060 |
Why?
|
| Animals, Domestic | 1 | 2004 | 11 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 1591 | 0.060 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2004 | 23 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 1057 | 0.060 |
Why?
|
| Incidence | 1 | 2008 | 1592 | 0.060 |
Why?
|
| P-Selectin | 1 | 2003 | 13 | 0.060 |
Why?
|
| Chromosomes, Human | 1 | 2003 | 66 | 0.060 |
Why?
|
| Fibronectins | 1 | 2024 | 101 | 0.060 |
Why?
|
| Breast Feeding | 1 | 2005 | 102 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2004 | 93 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2023 | 90 | 0.060 |
Why?
|
| Metabolomics | 1 | 2024 | 75 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2005 | 275 | 0.060 |
Why?
|
| Cockroaches | 1 | 2003 | 10 | 0.060 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2003 | 12 | 0.060 |
Why?
|
| Skin Tests | 1 | 2003 | 44 | 0.060 |
Why?
|
| Tandem Repeat Sequences | 1 | 2003 | 27 | 0.050 |
Why?
|
| Age Factors | 2 | 2021 | 1867 | 0.050 |
Why?
|
| Sheep | 1 | 2023 | 250 | 0.050 |
Why?
|
| Feces | 2 | 2015 | 327 | 0.050 |
Why?
|
| Linear Models | 1 | 2004 | 421 | 0.050 |
Why?
|
| Parity | 2 | 1999 | 96 | 0.050 |
Why?
|
| Cattle | 1 | 2023 | 375 | 0.050 |
Why?
|
| Nitrogen Dioxide | 1 | 2022 | 16 | 0.050 |
Why?
|
| Cell Line, Transformed | 2 | 2014 | 155 | 0.050 |
Why?
|
| Biodiversity | 2 | 2015 | 205 | 0.050 |
Why?
|
| Neurons | 2 | 2021 | 1580 | 0.050 |
Why?
|
| Africa, Western | 1 | 2002 | 11 | 0.050 |
Why?
|
| Cadherin Related Proteins | 1 | 2022 | 1 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2004 | 996 | 0.050 |
Why?
|
| Japan | 1 | 2022 | 303 | 0.050 |
Why?
|
| Paternity | 1 | 2002 | 8 | 0.050 |
Why?
|
| Proteomics | 1 | 2024 | 230 | 0.050 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2021 | 19 | 0.050 |
Why?
|
| Chemokines | 1 | 2022 | 74 | 0.050 |
Why?
|
| tau Proteins | 1 | 2022 | 74 | 0.050 |
Why?
|
| Gigantism | 1 | 2021 | 3 | 0.050 |
Why?
|
| Genes, erbB-2 | 1 | 2021 | 25 | 0.050 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2021 | 12 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 24 | 0.050 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2021 | 24 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 661 | 0.050 |
Why?
|
| Fasting | 1 | 2002 | 163 | 0.050 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2021 | 35 | 0.050 |
Why?
|
| Food Preferences | 1 | 2021 | 26 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2022 | 102 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 120 | 0.050 |
Why?
|
| Hypothalamus | 1 | 2021 | 79 | 0.050 |
Why?
|
| Electric Impedance | 1 | 2001 | 110 | 0.050 |
Why?
|
| Interleukin-17 | 1 | 2022 | 105 | 0.050 |
Why?
|
| Introns | 2 | 2014 | 299 | 0.050 |
Why?
|
| Cadherins | 1 | 2022 | 163 | 0.050 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2021 | 42 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 87 | 0.050 |
Why?
|
| Decidua | 1 | 2020 | 19 | 0.050 |
Why?
|
| Streptococcus pneumoniae | 1 | 2020 | 49 | 0.050 |
Why?
|
| Creatinine | 1 | 2001 | 293 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2021 | 78 | 0.050 |
Why?
|
| Prognosis | 1 | 2008 | 3773 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2021 | 133 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2020 | 4273 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2001 | 166 | 0.050 |
Why?
|
| Bronchioles | 1 | 2020 | 2 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2021 | 213 | 0.040 |
Why?
|
| Calcineurin | 1 | 2020 | 20 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 197 | 0.040 |
Why?
|
| Phylogeny | 1 | 2005 | 1182 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2001 | 223 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2020 | 151 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2001 | 302 | 0.040 |
Why?
|
| Lymphocyte Transfusion | 1 | 1999 | 41 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 2 | 1998 | 63 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 2000 | 97 | 0.040 |
Why?
|
| Meiosis | 2 | 2012 | 82 | 0.040 |
Why?
|
| Sample Size | 1 | 2000 | 128 | 0.040 |
Why?
|
| Eosinophilia | 1 | 2020 | 84 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 200 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 293 | 0.040 |
Why?
|
| Gestational Age | 2 | 1999 | 323 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2020 | 138 | 0.040 |
Why?
|
| Avoidance Learning | 1 | 1999 | 16 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 319 | 0.040 |
Why?
|
| Stem Cells | 1 | 2021 | 372 | 0.040 |
Why?
|
| Comorbidity | 1 | 2022 | 948 | 0.040 |
Why?
|
| Calcium Channels | 1 | 2020 | 182 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2021 | 327 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 363 | 0.040 |
Why?
|
| Mesoderm | 1 | 1999 | 124 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 167 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 1998 | 51 | 0.040 |
Why?
|
| Immunogenetics | 1 | 1998 | 7 | 0.040 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1998 | 11 | 0.040 |
Why?
|
| Histone Code | 1 | 2017 | 19 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2001 | 8203 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1574 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 1998 | 306 | 0.040 |
Why?
|
| Codon | 1 | 1997 | 122 | 0.040 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1997 | 28 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2000 | 988 | 0.040 |
Why?
|
| Point Mutation | 1 | 1998 | 245 | 0.040 |
Why?
|
| DNA Primers | 1 | 1998 | 543 | 0.040 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2017 | 179 | 0.040 |
Why?
|
| Gorilla gorilla | 1 | 1997 | 43 | 0.040 |
Why?
|
| Disease Progression | 1 | 2021 | 1488 | 0.030 |
Why?
|
| Lod Score | 2 | 2008 | 152 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 50 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2016 | 49 | 0.030 |
Why?
|
| Phospholipase D | 1 | 2015 | 13 | 0.030 |
Why?
|
| Fibroblasts | 1 | 1999 | 755 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 153 | 0.030 |
Why?
|
| Integrin alpha2 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2015 | 5 | 0.030 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2015 | 9 | 0.030 |
Why?
|
| STAT2 Transcription Factor | 1 | 2015 | 6 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 1999 | 1714 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 276 | 0.030 |
Why?
|
| Luteal Phase | 1 | 2015 | 14 | 0.030 |
Why?
|
| Survival Analysis | 1 | 1999 | 1533 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2015 | 112 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1521 | 0.030 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 1 | 2014 | 13 | 0.030 |
Why?
|
| HLA-B Antigens | 2 | 1985 | 27 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 2014 | 41 | 0.030 |
Why?
|
| Birth Intervals | 2 | 1985 | 7 | 0.030 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2014 | 14 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 69 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 39 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2014 | 96 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 1999 | 1796 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2014 | 74 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 1087 | 0.030 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2013 | 14 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 177 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 170 | 0.030 |
Why?
|
| Models, Molecular | 1 | 1997 | 1296 | 0.030 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2013 | 23 | 0.030 |
Why?
|
| Temperature | 1 | 2014 | 400 | 0.030 |
Why?
|
| Semen | 1 | 2012 | 13 | 0.030 |
Why?
|
| Sperm Motility | 1 | 2012 | 11 | 0.030 |
Why?
|
| Centromere | 1 | 2012 | 26 | 0.030 |
Why?
|
| Canada | 1 | 2012 | 208 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2014 | 684 | 0.030 |
Why?
|
| Caribbean Region | 1 | 2011 | 20 | 0.020 |
Why?
|
| Genotyping Techniques | 1 | 2012 | 69 | 0.020 |
Why?
|
| Fathers | 1 | 2012 | 70 | 0.020 |
Why?
|
| Telomere | 1 | 2012 | 114 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 529 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 1706 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 160 | 0.020 |
Why?
|
| Viral Load | 1 | 2011 | 145 | 0.020 |
Why?
|
| Methionine | 1 | 2010 | 65 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 2009 | 48 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2362 | 0.020 |
Why?
|
| RNA | 1 | 2013 | 578 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2012 | 575 | 0.020 |
Why?
|
| Paternal Age | 1 | 2008 | 5 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2008 | 46 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2015 | 964 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2007 | 55 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2006 | 149 | 0.020 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2005 | 18 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 1985 | 59 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 51 | 0.020 |
Why?
|
| Markov Chains | 1 | 2005 | 127 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2005 | 225 | 0.020 |
Why?
|
| Ultrasonography | 1 | 1987 | 711 | 0.020 |
Why?
|
| Contraception | 1 | 1985 | 92 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 3373 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 360 | 0.010 |
Why?
|
| Cats | 1 | 2004 | 305 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2004 | 151 | 0.010 |
Why?
|
| Genetic Techniques | 1 | 2003 | 73 | 0.010 |
Why?
|
| Dogs | 1 | 2004 | 704 | 0.010 |
Why?
|
| Food Hypersensitivity | 1 | 2004 | 70 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 727 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 234 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2002 | 79 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2002 | 100 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 2552 | 0.010 |
Why?
|
| Austria | 1 | 1989 | 16 | 0.010 |
Why?
|
| Inbreeding | 1 | 1989 | 45 | 0.010 |
Why?
|
| Probability | 1 | 1989 | 353 | 0.000 |
Why?
|
| Fetal Death | 1 | 1987 | 57 | 0.000 |
Why?
|